兩連板的景峯醫藥(000908.SZ):近期披露2020年度預虧7億至10億元
格隆匯 2 月 7日丨連續2個漲停的景峯醫藥(000908.SZ)發佈股票交易異常波動公吿,經向公司管理層、控股股東詢問,公司、控股股東不存在關於公司的應披露而未披露的重大事項;
公司於2021年1月30日披露了《2020年度業績預吿》(公吿編號:2021-017號),預計2020年度歸屬於上市公司股東的淨利潤為虧損7億元至10億元;扣除非經常性損益後的淨利潤為虧損9億元至13億元,預計2020年度營業收入為7.5億元至10億元;扣除後營業收入為7.4億元至9.9億元。經公司初步測算,公司2020年擬對企業合併形成的商譽計提減值準備3億-3.7億元,擬對企業對外投資形成的長期股權投資計提減值準備1.4億元-1.7億元,最終減值計提金額將由公司聘請具備證券期貨從業資格的評估機構及審計機構進行評估和審計後確定。此次業績預吿是公司財務部門初步測算的結果,具體財務數據以公司2020年度報吿內容為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.